Toshihisa Itaya

Toshihisa Itaya is a notable inventor based in Kawasaki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiulcer agents. With a total of two patents to his name, Itaya's work has had a meaningful impact on medicinal chemistry.

Latest Patents

Itaya's latest patents include innovative compounds such as antiulcer phenoxypropylamine derivatives. These derivatives are characterized by a general formula where R1 can be a hydrogen atom or a methyl or ethyl group. R2 and R3 can represent lower alkyl groups or form a linear alkylene group with 4 to 7 carbon atoms, which may be substituted by hydroxyl or hydroxymethyl groups. Additionally, R4 can be a hydrogen atom or a specific group that includes various functional groups. Another patent involves the preparation of di- or tri-substituted aluminum salts of carboxyl group-containing, pharmaceutically effective compounds. This process includes reacting carboxyl group-containing compounds with an organic aluminum compound, leading to novel pharmaceutical applications.

Career Highlights

Toshihisa Itaya is currently employed at Teikoku Hormone Mfg. Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work focuses on developing effective medicinal compounds that address critical health issues.

Collaborations

Itaya has collaborated with notable coworkers such as Kenyu Shibata and Nobuaki Yamakoshi. Their combined expertise has contributed to the advancement of pharmaceutical research and development.

Conclusion

Toshihisa Itaya's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work continues to influence the development of effective medicinal treatments.